Industry
Health Care & Social Assistance Cannabis
Keywords
healthcare biotechnology life sciences hematology oncology obstructive sleep apnea excessive sleepiness small cell lung cancer epilepsy neuroscience cannabinoid science sleep disorders narcolepsy cataplexy leukemia
GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country.[4] Another cannabis-based product, Epidiolex, for treatment of epilepsy, was approved for treatment of epilepsy in 2018. read more
GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country.[4] Another cannabis-based product, Epidiolex, for treatment of epilepsy, was approved for treatment of epilepsy in 2018. read more

Sponsor Details

People
If you currently work at this organization, click the “Do you work here?” button to request editing privileges.
This SponsorPitch page is about GW Pharmaceuticals and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with GW Pharmaceuticals , though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Do you work here button to request management privileges. All trademarks, service marks and copyrights are property of their respective owners.